Manufacturers Life Insurance Company, The Alnylam Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 191,382 shares of ALNY stock, worth $46.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

191,382

Previous 329,037 41.84%

Holding current value

$46.7 Million

Previous $80 Million 34.16%

% of portfolio

0.05%

Previous 0.08%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $32.2 Million - $39.5 Million	-137,655 Reduced 41.84%	191,382 $52.6 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $1.14 Million - $1.97 Million	-7,988 Reduced 2.37%	329,037 $80 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $556,005 - $752,169	-3,795 Reduced 1.11%	337,025 $50.4 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $2.28 Million - $2.96 Million	-15,043 Reduced 4.23%	340,820 $65.2 Million
Q3 2023 Nov 15, 2023	BUY	$170.77 - $211.65 $4.99 Million - $6.18 Million	29,209 Added 8.94%	355,863 $63 Million
Q2 2023 Aug 11, 2023	SELL	$185.01 - $212.05 $3.06 Million - $3.51 Million	-16,566 Reduced 4.83%	326,654 $62 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $1.04 Million - $1.34 Million	-5,692 Reduced 1.66%	337,528 $67.6 Million
Q4 2022 Aug 11, 2023	SELL	$185.53 - $241.31 $105 Million - $137 Million	-567,340 Reduced 62.31%	343,220 $81.6 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $92 Million - $120 Million	-495,795 Reduced 59.09%	343,220 $81.6 Million
Q3 2022 Aug 11, 2023	SELL	$138.54 - $232.0 $103 Million - $173 Million	-745,275 Reduced 45.01%	910,560 $182 Million
Q3 2022 Nov 03, 2022	SELL	$138.54 - $232.0 $113 Million - $190 Million	-816,820 Reduced 49.33%	839,015 $169 Million
Q2 2022 Aug 11, 2023	SELL	$120.42 - $169.29 $11.5 Million - $16.1 Million	-95,228 Reduced 5.44%	1,655,835 $242 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $41.2 Million - $57.9 Million	-341,927 Reduced 17.12%	1,655,835 $241 Million
Q1 2022 Aug 11, 2023	BUY	$127.18 - $173.91 $180 Million - $246 Million	1,413,535 Added 418.79%	1,751,063 $286 Million
Q1 2022 May 20, 2022	BUY	$127.18 - $173.91 $37.5 Million - $51.3 Million	295,092 Added 17.33%	1,997,762 $327 Million
Q4 2021 Feb 16, 2022	SELL	$159.56 - $209.29 $4.59 Million - $6.02 Million	-28,763 Reduced 1.66%	1,702,670 $289 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $4.14 Million - $5.06 Million	-24,375 Reduced 1.39%	1,731,433 $327 Million
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $19.4 Million - $26.7 Million	150,950 Added 9.41%	1,755,808 $298 Million
Q1 2021 May 03, 2021	BUY	$126.83 - $175.69 $17.9 Million - $24.7 Million	140,769 Added 9.61%	1,604,858 $227 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $37.1 Million - $44.3 Million	301,315 Added 25.91%	1,464,089 $190 Million
Q3 2020 Nov 09, 2020	SELL	$121.19 - $165.49 $7.23 Million - $9.87 Million	-59,658 Reduced 4.88%	1,162,774 $169 Million
Q2 2020 Aug 10, 2020	SELL	$104.21 - $156.44 $5.96 Million - $8.95 Million	-57,222 Reduced 4.47%	1,222,432 $181 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $98 Million - $141 Million	1,052,417 Added 463.14%	1,279,654 $139 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $567,170 - $945,638	-7,612 Reduced 3.24%	227,237 $26.2 Million
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $341,525 - $423,028	-4,817 Reduced 2.01%	234,849 $19 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $2.07 Million - $2.92 Million	31,429 Added 15.09%	239,666 $17.4 Million
Q1 2019 May 13, 2019	SELL	$72.76 - $93.45 $455,041 - $584,436	-6,254 Reduced 2.92%	208,237 $19.5 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $89,367 - $125,958	1,426 Added 0.67%	214,491 $15.6 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $18.4 Million - $25.7 Million	209,846 Added 6518.98%	213,065 $18.6 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $1,854 - $2,263	-21 Reduced 0.65%	3,219 $317,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $8,694 - $11,140	75 Added 2.37%	3,240 $386,000
Q4 2017 Feb 08, 2018	BUY	$114.49 - $139.98 $38,926 - $47,593	340 Added 12.04%	3,165 $402,000
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $204,897 - $334,112	2,825	2,825 $332,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Alnylam Pharmaceuticals, Inc. Transaction History